Chun-Wang Lin1, Xiang-Lin Zeng2, Jin-Feng Zhang3, Xiu-Hui Meng3. 1. Foshan Shunde Women and Children Health Care Hospital, Shunde, Foshan, Guangdong, P. R. China. Electronic address: 494812590@qq.com. 2. First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, P. R. China. 3. Foshan Shunde Women and Children Health Care Hospital, Shunde, Foshan, Guangdong, P. R. China.
Abstract
BACKGROUND: Plasma N-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of heart failure (HF). However, the optimal cutoff value of plasma NT-proBNP for the diagnosis of HF in children is unknown. The objective of this study was to determine the appropriate cutoff value of plasma NT-proBNP for the diagnosis of HF in children ≤14 years old. METHODS AND RESULTS: Plasma NT-proBNP concentrations were detected in pediatric HF patients using standard clinical assays. Patients were stratified into 4 groups by age: 0-1 year, 1-3 years, 4-7 years, and 8-14 years. Case-matched healthy children were recruited as control subjects. HF was diagnosed with the use of the modified Ross score. The optimal cutoff value of plasma NT-proBNP for the diagnosis of HF was determined by analyzing receiver operating characteristic (ROC) curves and the resulting sensitivity, specificity, and Youden index (J). In healthy children, plasma NT-proBNP level and age were negatively correlated (r = -0.739; P < .001). In HF patients aged 0-1 year, 1-3 years, 4-7 years, and 8-14 years, respectively, areas under the ROC curves were 0.795, 0.786, 0.783, and 0.696; 95% confidence intervals were 0.689-0.901, 0.669-0.903, 0.662-0.904, and 0.487-0.905; and J values were 0.715, 0.708, 0.706, and 0.679. Optimal cutoff values of plasma NT-proBNP for the diagnosis of HF were 502 ng/L, 456 ng/L, 445 ng/L, and.355 ng/L. CONCLUSIONS: Age-stratified analysis of plasma NT-proBNP levels in children provides new parameters for diagnosing HF.
BACKGROUND: Plasma N-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of heart failure (HF). However, the optimal cutoff value of plasma NT-proBNP for the diagnosis of HF in children is unknown. The objective of this study was to determine the appropriate cutoff value of plasma NT-proBNP for the diagnosis of HF in children ≤14 years old. METHODS AND RESULTS: Plasma NT-proBNP concentrations were detected in pediatric HF patients using standard clinical assays. Patients were stratified into 4 groups by age: 0-1 year, 1-3 years, 4-7 years, and 8-14 years. Case-matched healthy children were recruited as control subjects. HF was diagnosed with the use of the modified Ross score. The optimal cutoff value of plasma NT-proBNP for the diagnosis of HF was determined by analyzing receiver operating characteristic (ROC) curves and the resulting sensitivity, specificity, and Youden index (J). In healthy children, plasma NT-proBNP level and age were negatively correlated (r = -0.739; P < .001). In HF patients aged 0-1 year, 1-3 years, 4-7 years, and 8-14 years, respectively, areas under the ROC curves were 0.795, 0.786, 0.783, and 0.696; 95% confidence intervals were 0.689-0.901, 0.669-0.903, 0.662-0.904, and 0.487-0.905; and J values were 0.715, 0.708, 0.706, and 0.679. Optimal cutoff values of plasma NT-proBNP for the diagnosis of HF were 502 ng/L, 456 ng/L, 445 ng/L, and.355 ng/L. CONCLUSIONS: Age-stratified analysis of plasma NT-proBNP levels in children provides new parameters for diagnosing HF.
Keywords:
N-Terminal fragment of pro–B-type natriuretic peptide; age stratification; children up to 14 years of age; cutoff points; heart failure diagnosis
Authors: Matthew D Zinn; Michael J Wallendorf; Kathleen E Simpson; Ashley D Osborne; James K Kirklin; Charles E Canter Journal: Pediatr Transplant Date: 2018-01-29
Authors: Fernanda Lima-Setta; Maria Clara de Magalhães-Barbosa; Gustavo Rodrigues-Santos; Elaine Augusta das Neves Figueiredo; Melissa de Lorena Jacques; Raquel de Seixas Zeitel; Roberto Sapolnik; Cibelle Teixeira da Siva Borges; Vanessa Soares Lanziotti; Roberta Esteves Vieira de Castro; Ana Paula Novaes Bellinat; Thiago Peres da Silva; Felipe Rezende Caino de Oliveira; Bárbara Carvalho Santos Dos Reis; Natália Almeida de Arnaldo Silva Rodriguez Castro; João Henrique Garcia Cobas Macedo; Ana Carolina Cabral Pinheiro Scarlato; Paula Marins Riveiro; Isabele Coelho Fonseca da Mota; Vivian Botelho Lorenzo; Natalia Martins Lima de Lucena; Zina Maria Almeida de Azevedo; Antonio José L A Cunha; Arnaldo Prata-Barbosa Journal: J Pediatr (Rio J) Date: 2020-11-09 Impact factor: 2.990